Trial Profile
Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Evofosfamide (Primary)
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 06 Sep 2018 Status changed from recruiting to completed.
- 07 May 2015 New trial record